Enhanced Immunoreactivity for Basic Fibroblast Growth Factor (FGF2) in the Adult Rat Spinal Cord in Experimental Syringomyelia

DOI
  • MIYATAKE Shin
    Department of Sports Medicine and Joint Surgery, Hokkaido University Graduate School of Medicine
  • ONODERA Shin
    Department of Sports Medicine and Joint Surgery, Hokkaido University Graduate School of Medicine
  • SANO Toshiaki
    Department of Human Pathology, Institute of Health Biosciences, The University of Tokushima Graduate School
  • KATOH Shinsuke
    Department of Orthopaedics, The University of Tokushima Graduate School
  • IKATA Takaaki
    Department of Orthopaedics, The University of Tokushima Graduate School

この論文をさがす

抄録

This study design is experimental study using a syringomyelia model. Fibroblast growth factor (FGF) 2 is an endogenous neurotrophic growth factor in the central nervous system (CNS). The aim of this study was to examine how the spatial and temporal expression of FGF2 in the rat spinal cord changes over the 20-week period following the induction of experimental syringomyelia in rats. Rats were subjected to intracisternal injection of kaolin, which causes syringomyelia. The rats were sacrificed at 0, 3, 7, 10, and 12 weeks, and the spinal cord was histologically examined. The localization of FGF-2 and glial fibrillary acidic protein (GFAP) was also examined by immunohistochemistry. In the normal, slight FGF2 immunoreactivity was observed in a few axons and myelin sheaths in the white matter of the spinal cord. Three weeks after injection, no syrinx formation and little vacuolar degeneration were seen in the white matter, while a mild increase in FGF2 immunoreactivity were in some axons and myelin sheaths. At 7, 10, and 20 weeks, the central canal and the syrinx formation were enlarged. These changes were followed by demyelination. The number of FGF2-positive axons and myelin sheaths increased over time, and this seemed to correlate positively with the progress of the vacuolar degenerative changes. These results showed a detailed expression pattern of FGF2 during the establishment process of experimental syringomyelia, and suggest that a role played by FGF2 in the pathophysiology of this disease.

収録刊行物

  • Nano Biomedicine

    Nano Biomedicine 1 (2), 167-175, 2009

    ナノ・バイオメディカル学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ